These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 328066)

  • 21. Immunoassay methods for the detection of antigens and antibodies: the reverse plaque-forming cell assay.
    Molinaro GA; Eby WC; Molinaro CA
    Methods Enzymol; 1981; 73(Pt B):326-38. PubMed ID: 7029204
    [No Abstract]   [Full Text] [Related]  

  • 22. The kinetics of hemolytic plaque formation. III. Inhibition of plaques by antigen.
    DeLisi C
    J Theor Biol; 1975 Jun; 51(2):337-45. PubMed ID: 49461
    [No Abstract]   [Full Text] [Related]  

  • 23. A pre-amplified reverse hemolytic plaque assay.
    Makonkawkeyoon S; Vithayasai V
    J Immunol Methods; 1983 Sep; 62(3):365-71. PubMed ID: 6350466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The kinetics of hemolytic plaque formation. II. Inhibition of plaques by hapten.
    DeLisi C
    J Theor Biol; 1975 Jun; 51(2):313-35. PubMed ID: 49460
    [No Abstract]   [Full Text] [Related]  

  • 25. Failure of PFC inhibition assays to distinguish idiotypically between clonotypes that are readily distinguishable by RIA analysis.
    Schepart BS; Mayers GL; Bankert RB
    J Immunol; 1985 Sep; 135(3):1683-9. PubMed ID: 2410500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hemolytic activity of some strains belonging to genus Vibrio.
    Islail A; Ciufecu C; Năcescu N; Cedru C
    Arch Roum Pathol Exp Microbiol; 1987; 46(3):211-24. PubMed ID: 3329505
    [No Abstract]   [Full Text] [Related]  

  • 27. [Methodological studies on the hemolytic anti-bovine gamma globulin plaque technic].
    Malberg K; Teich E; Schäffner H; Ambrosius H
    Allerg Immunol (Leipz); 1984; 30(2):110-6. PubMed ID: 6207718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reverse hemolytic plaque assays: versatility in the study of secretion.
    Boockfor FR; Fidan M
    Methods; 2004 Aug; 33(4):273-80. PubMed ID: 15183175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A reverse hemolytic plaque assay for the detection of prostaglandin production by individual cells in vitro.
    Birek C; Brunette DM; Heersche JN; Wang HM; Johnston MG
    Exp Cell Res; 1980 Sep; 129(1):95-101. PubMed ID: 7000524
    [No Abstract]   [Full Text] [Related]  

  • 30. Circulating and mitogen-induced immunoglobulin-secreting cells in human peripheral blood: evaluation by a modified reverse hemolytic plaque assay.
    Ginsburg WW; Finkelman FD; Lipsky PE
    J Immunol; 1978 Jan; 120(1):33-9. PubMed ID: 342605
    [No Abstract]   [Full Text] [Related]  

  • 31. Detection of cells producing antibody to hepatitis B surface antigen by an indirect hemolytic plaque assay.
    Johnson RA; Hoofnagle JH; Gerety RJ; Barker LF; Merchant B
    Intervirology; 1974; 4(5):287-91. PubMed ID: 4618843
    [No Abstract]   [Full Text] [Related]  

  • 32. A plaque assay for all cells secreting Ig of a given type or class.
    Gronowicz E; Coutinho A; Melchers F
    Eur J Immunol; 1976 Aug; 6(8):588-90. PubMed ID: 789096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between the sensitivity of the hemolytic plaque-forming cell assay and the enzyme-linked immunospot assay in detecting B cells producing trinitrophenyl- or sheep erythrocyte-specific IgM and IgG antibodies.
    Heyman B; Brogren I; Klareskog L
    J Immunol Methods; 1991 Jun; 139(2):293-6. PubMed ID: 2045665
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of nephelometric and hemolytic techniques for determination of antistreptolysin O antibodies.
    Pacifico L; Mancuso G; Properzi E; Ravagnan G; Pasquino AM; Chiesa C
    Am J Clin Pathol; 1995 Apr; 103(4):396-9. PubMed ID: 7726133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cells involved in the immune response. XXX. An evaluation of the different assays to demonstrate rabbit spleen plaque-forming cells. Enhancement of the assay by anti-target cell antibodies.
    Richter M; Berry M; Kazaniwsky N
    J Immunol Methods; 1981; 46(1):77-83. PubMed ID: 7026689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a hemolytic plaque assay for glutamic acid, lysine-containing polypeptides: demonstration that nonresponder mice produce antibodies to these peptides when conjugated to an immunogenic carrier.
    Cheung NK; Dorf ME; Benacerraf B
    J Immunol; 1977 Sep; 119(3):901-5. PubMed ID: 70477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppression with cyclophosphamide: effect on antibody plaque-forming spleen cells and on hemolytic antibodies production.
    Bohunická E; Koza I; Kuzela S; Krempaský V; Ujházy V
    Neoplasma; 1972; 19(6):611-20. PubMed ID: 4596308
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of complement-mediated hemolysis by rheumatoid arthritis sera studies in agarose gel.
    Kasukawa R; Yoshida T; Milgrom F
    Int Arch Allergy Appl Immunol; 1970; 38(2):168-74. PubMed ID: 4984330
    [No Abstract]   [Full Text] [Related]  

  • 39. Hybridomas producing hemolytic plaques used to study the relationship between monoclonal antibody affinity and the efficiency of plaque inhibition with increasing concentrations of antigen.
    Bankert RB; Mazzaferro D; Mayers GL
    Hybridoma; 1981; 1(1):47-58. PubMed ID: 6765319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of immunoglobulin-secreting lymphocytes by the use of a hemolytic plaque assay in liquid phase.
    Beaudoin R; Valet JP; Hébert J
    J Immunol Methods; 1980; 35(1-2):91-5. PubMed ID: 7009751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.